This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Investment firm Kuwait LifeSciences Company's Dr. Mussaad M. Al-Razouki gives a breakdown of recently filed or finalized digitalhealth SPACs, as well as a list of unicorns ripe for a potential merger.
In the Age of COVID, over 90,000 new health apps were released, as the supply of digital therapeutics and wearables grew in 2020. Evidence supporting the use of digitalhealth tools if growing, tracked in DigitalHealth Trends 2021: Innovation, Evidence, Regulation, and Adoption from IQVIA Institute for Human Data Science.
We’re excited to announce the launch of the LifeSciences Today Podcast by Healthcare IT Today. We’ve been thinking about getitng into the world of LifeSciences for a long time. We often use the same terms like digitalhealth and patient engagement. A match made in heaven.
Atropos Health , renowned for its evidence-based medicine, is expanding its award-winning Evidence Platform to redefine lifesciences applications. The company has added Dr. Sean Khozin, MD, MPH and Gerry McDougall to its LifeSciences Advisory Board, strengthening its growth in the field.
Together, the organizations will seek to harness the power of generative AI to help pharmaceutical and lifescience manufacturers drive efficiencies and business value while improving patient outcomes. Companies that find the optimal balance of human and AI-powered services will leap ahead in every industry, and pharma is no different.
In the fast-paced world of lifesciences, embracing innovation has become a top priority for companies striving to stay ahead of the curve. With digital transformation, innovation is no longer a “nice to have” but the driving force behind lifesciences organizations’ success.
Diabetes management company Hygieia extended its Series B round, and Autonomize AI, a workflow platform for healthcare and lifesciences, also announced funding.
At HIMSS23, Steven Lazer, global healthcare and lifesciences chief technology officer at Dell Technologies, joined MobiHealthNews to discuss Dell's work within digitalhealth.
In addition, MDisrupt will add new features to the marketplace platform through a strategic collaboration with the Association to meet the needs of its members, providing new ways for them to engage with the health technology, health services, medical device, and lifesciences sectors.
MassBio's Luba Greenwood also discusses her decision to leave Verily in order to pursue teaching the intersection of lifescience and technology at Harvard.
Reenita Das, partner and SVP for healthcare and lifesciences at Frost and Sullivan, said that femtech companies only accounted for 1.8% of total digitalhealth investments in 2020.
The lifescience company created an initiative called the G4A DigitalHealth Partnership Program, which provides resources to both experienced and new digitalhealth companies.
A global survey of digitalhealth and wellness practitioners found that although many leaders feel optimistic about the future of the industry, the overwhelming majority also perceive the sector to be relatively high risk. WHY IT MATTERS. ON THE RECORD.
NEW YORK–(BUSINESS WIRE)– BTIG announced today the “BTIG Snowbird MedTech, DigitalHealth, LifeScience and Diagnostic Tools Conference” will take place on Tuesday, February 14 through Thursday, February 16, 2023.
Frontiers Health 2025 , the premier global conference on health innovation and lifesciences, will celebrate its 10th anniversary on November 1112, 2025 , at the bcc Berlin Congress Center in Berlin, Germany. Right now, Super Early Bird pricing is available, making this the best time to register.
BOSTON and SEATTLEMarch 25, 2025 Xealth , the leader in digitalhealth enablement for health systems, today announced a strategic investment from Morningside Ventures , a leading investor in healthcare innovation. We are thrilled to work with Morningside Ventures.”
With this fund, XGEN Venture will be working alongside talented scientists and entrepreneurs to create and invest in up to 15 companies, delivering impactful solutions to patients through new therapeutics, medical devices, diagnostics and digitalhealth solutions. of the total fund. “We
This capability is attracting pharmaceutical and lifescience companies, health care providers and research organizations to take a closer look at Seqster’s offering. Takeda is one of the organizations that has implemented Seqster’s solution, leveraging real-time data for research and patient services.
The funding will support Briya’s mission to transform how data is exchanged between healthcare organizations and lifesciences organizations, with particular emphasis on supporting the United States health ecosystem. The company’s scalable data exchange platform enables hospitals to capitalize on their patient data.
–(BUSINESS WIRE)– #Biotech –Taking a people-first approach, BioscienceLA, the ecosystem accelerator for lifesciences in Greater Los Angeles, has launched its inaugural Leadership Catalyst Program for trailblazers in biotechnology and related sectors. We are delighted to be part of this impactful program.”
(Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the Company will participate in the BTIG MedTech, DigitalHealth, LifeScience & Diagnostic Tools Conference, which takes place February 14 – 16, 2023 in Snowbird, UT.
As the exclusive Rainbird service partner in lifesciences, Klick will pair its industry-leading knowledge, data, and tools with Rainbird’s decision intelligence automation platform to eliminate organizational bottlenecks and maximize opportunities for biopharmaceutical organizations bringing life-saving therapies to market.
Our mission is to accelerate the commercialization of breakthrough innovations like the AUTAC platform for health impact, and we welcome Automera and ALSP to Singapore’s growing lifesciences translational community.” Together, we advance Singapore as a global lifesciences translational hub.
During the first year of the COVID-19 pandemic, the health care sector was profoundly affected by cyber-attacks on connected devices, we learn in the report, Rise of the Machines 2021: State of Connected Devices – IT, IoT, IoMT and OT from Ordr. Back to the Ordr report, noting the rise of also the Internet of Stranger Things, abounding.
Trust has become a key currency in provider/patient/supplier relationships: 94% of health executives say treating customers as partners is important to gain trust, according to the DigitalHealth Tech Vision 2018 from Accenture. Accenture’s vision this year is built on five pillars: Citizen AI. Extended Reality. Data Veracity.
Expert Health Tech Leader Brings Extensive Experience in Connected Care, LifeSciences, and Chronic Condition Management to Drive Global Growth Glooko, Inc. , About Glooko Glooko improves the health outcomes of people with chronic conditions through its personalized, intelligent, connected care and lifesciences platform.
About EVERSANA EVERSANA is a leading independent provider of global services to the lifesciences industry. The companys integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers.
Labviva’s B2B e-commerce marketplace enables lifesciences and research organizations to manage organizational purchasing and procurement to accelerate the pace of lifescience research. We’re thrilled to support Labviva, as they revolutionize the lifesciences procurement industry.
DigitalHealth Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings.
Over 100 million Americans are weighed down by medical debt, which contributes to 65% of all bankruptcies.TailorMed has built the nations largest affordability network, uniting patients, providers, pharmacies, and lifescience companies to solve this critical challenge.
“Compare digitalhealth to airlines, cruise lines, and other industries” and the sector looks quite privileged, opined Matthew Holt in a discussion on a study diving deeply into the State of DigitalHealth , conducted by Catalyst @ Health 2.0 and sponsored by WIPFLI. million, with a median of $3.9
The public health crisis accelerated “what’s next” for health care delivery, detailed in A New Era of Virtual Health, a report published by TripleTree. TripleTree is an investment bank that has advised health care transactions since 1997.
When announced, the news was a signal that health care and the larger tech-enabled ecosystem that supports health and well-being is embedded in peoples’ everyday lives. We can expect to see more women-related health tech featured at CES 2022, including on education panels and speaking platforms.
Google Cloud has announced the launch of enhanced AI-powered tools aimed at advancing lifesciences. The company is also exploring generative AI to augment existing tools and build entirely revolutionary ways to advance the lifesciences sector.
The event, moderated by Francesco Cerruti , General Director of Italian Tech Alliance, was attended by more than 100 guests including investors, startups, lifesciences companies and industry experts and professionals. The evolution of the digitalhealth ecosystem in Italy greatly benefits from a program like VITA.
Launched in 2022, Autonomize AI provides software products to lower costs and improve operational efficiencies for healthcare and lifesciences organizations. About Autonomize AI Founded in 2022, Autonomize AI specializes in AI solutions for healthcare and life-sciences organizations.
. “The antiquated CRO model is failing the industry and failing patients, with inefficiencies and misaligned incentives propelling costs and causing researchers to stumble before their breakthroughs can reach patients,” said Meri Beckwith , Co-Founder of Lindus Health.
Basel, Switzerland 28, January 2025 Lyfegen , a global innovator in drug market access, pricing, and rebate management, has announced a transformative collaboration with EVERSANA , a leading provider of global commercial services to the lifesciences industry, to revolutionize drug pricing and access through artificial intelligence-driven insights.
Frontiers Health has announced that the 2023 edition of the global conference will be held from 8 to 10 November 2023 , following last year’s great success in terms of attendance and involvement of the players that make up the diverse digitalhealth ecosystem.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content